コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 eric immune receptors (CR) against human 5T4 oncofetal Ag (h5T4) and evaluated their tumor therapeuti
5 During tumor development in mice and humans, oncofetal Ag/immature laminin receptor (OFA/iLRP)-specif
8 ese novel observations demonstrate that this oncofetal antigen can serve as an effective tumor reject
12 deaminated sialic acids KDN (2), a potential oncofetal antigen, and N-acetylneuraminic acid (Neu5Ac,
13 telomerase reverse transcriptase, G250, and oncofetal antigen, but not against self-antigens express
18 sis with one of these products confirmed the oncofetal expression of transcripts related to TuAg.1/pE
20 paid to the deposit of collagen, we identify oncofetal fibronectin (FN) as a major and obligate compo
21 ) TGF-beta treatment caused up-regulation of oncofetal fibronectin (onfFN), which is defined by mAb F
25 development, suggesting that let-7-regulated oncofetal genes (LOG) may become reexpressed in cancer c
26 ion embryonic program that encompasses known oncofetal genes as well as oncogenes not previously asso
27 ncovers a miRNA-repressed network containing oncofetal genes Imp1, Imp2, and Imp3 (Imp1-3) that is up
28 subgroup of hHCCs, with shared activation of oncofetal genes including Igf2, correlating with CpG hyp
31 Human carcinoembryonic antigen (CEA) is an oncofetal glycoprotein overexpression of which by gastro
32 ryonic antigen (CEA) is a well-characterized oncofetal glycoprotein whose overexpression by human car
36 r the diagnosis and management of HCC, is an oncofetal protein expressed in a majority of HCCs but ra
40 actor 2 mRNA-binding protein-1 (IMP-1) is an oncofetal protein that binds directly to and stabilizes
42 e type 3 iodothyronine deiodinase (D3) is an oncofetal protein that is rarely expressed in adult life
44 rowth factor-2 mRNA binding protein 3) is an oncofetal protein whose expression is prognostic for poo
50 pression; and high coordinated expression of oncofetal proteins and stem-cell markers, while low-risk
51 We aimed to investigate whether IMP3, an oncofetal RNA-binding protein, can be used as a biomarke
52 lted from neonatal-specific expression of an oncofetal RNA-binding protein, IGF2BP3, which prevented
54 ing proteins (IGF2BPs), are highly conserved oncofetal RNA-binding proteins (RBPs) that regulate RNA
55 CRD-BP/IGF2BP1 has been characterized as an "oncofetal" RNA binding protein typically highly expresse
57 break immune tolerance to ROR1, which is an oncofetal surface antigen and survival-signaling recepto
58 ithelial cells that express MUC1 bearing the oncofetal Thomsen-Friedenreich antigen (Galbeta1,3 GalNA
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。